Characterizing safety and efficacy in ovarian cancer patients with thromboembolism treated with rivaroxaban.

e18720Background: There is a paucity of real-world data regarding rates of recurrent venous thromboembolism (VTE), major bleeding and all-cause mortality among ovarian cancer patients with thrombos...